Product News from the 11/07/06 News Brief

Share this article:
The FDA has approved the first generic version of Galderma’s MetroGel-Vaginal (metronidazole), a treatment for bacterial vaginosis. The generic version, Metronidazole Vaginal Gel, is manufactured by QLT of Fort Collins, CO. The company is eligible for 180 days of generic drug exclusivity. NovaDel Pharma said its NitroMist (nitroglycerin lingual aerosol) has been approved by the FDA for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. North American commercial rights for NitroMist have been licensed to Par Pharmaceutical.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.